Please login first

The 3rd International Electronic Conference on Brain Sciences

Part of the 1st International Electronic Conference on Brain Sciences series
1–15 Oct 2022
Abstract Submission
25th July 2022
Acceptance Notification
5th August 2022
File Submission
5th September 2022

Clinical Neuroscience, Cognitive Neuroscience, Systems Neuroscience, Molecular and Cellular Neuroscience, Developmental Neuroscience, Behavioral Neuroscience and Environmental Neuroscience
Add this event to bookmarks
Submit Abstract Contact Us

The deadline for abstract submissions is extended to 25 July 2022 .

You will be notified about the acceptance of your abstract by 5 August 2022.

Do not miss the chance to participate in IECBS 2022!

Welcome from the Chair

You are cordially invited to participate in the 3rd International Electronic Conference on Brain Sciences (IECBS2022). This event aims to bring together researchers working in the field of neuroscience, to present and discuss their recent contributions, without the need for travel.

The field of neuroscience is one of the most important frontiers in biomedical studies, as many of the details that control brain function are still not well understood. This makes the study of the nervous system very exciting and fast moving. This conference will address a variety of research topics which reflect some of the current areas of focus. Topics of the conference will be organized around the following 10 sessions:

  • Behavioral neuroscience
  • Molecular and cellular neuroscience
  • Developmental neuroscience
  • Neuropsychology
  • Systems neuroscience
  • Sensory and motor neuroscience
  • Computational neuroscience and neuroinformatics
  • Neurorehabilitation
  • Neurotechnology and neuroimaging
  • Poster session

All accepted file submissions will be published in the Biology and Life Sciences Forum, the proceedings of the conference, and authors are invited to elaborate their abstracts into full manuscripts that will be considered for publication in Brain Sciences, with a 20% discount on the APC. Brain Sciences is an open access MDPI journal in the field of neuroscience. The journal is indexed in the Sciences Citation Indexing Expanded (SCIE, Impact Factor: 3.333), Scopus, and other databases. Citations are available in PubMed; full text archived in PubMed Central (PMC). Please visit the following website for more information.

Important Dates
• Abstract Submission: 1 July 2022 25 July 2022
• Notification of Acceptance: 22 July 2022 5 August 2022
• Submission of Full files: 19 August 2022 5 September 2022
• Conference Date: 1–15 October 2022

You are welcome both to upload and present your work and to attend the conference completely free of charge.

Please do not hesitate to contact us if you have questions.

Best wishes,
Prof. Dr. Stephen D. Meriney
Chair of the 3rd International Electronic Conference on Brain Sciences

Event Chair

Prof. Dr. Stephen D. Meriney

Department of Neuroscience, University of Pittsburgh, Pittsburgh, USA

Stephen D. Meriney completed his PhD in Physiology/Neuroscience at the University of Connecticut with Dr. Guillermo Pilar in 1986, where he studied the parasympathetic control of intrinsic eye muscles. He then moved to the Jerry Lewis Neuromuscular Research Centre at the University of California, Los Angeles (UCLA) as a postdoctoral fellow, and then became an assistant research physiologist there, with Dr. Alan Grinnell, and studied voltage-gated calcium channels and synaptic mechanisms at the neuromuscular junction. He has been at the University of Pittsburgh since 1993, where he is currently a Professor, and Chair of the Department of Neuroscience, with a secondary appointment in the Department of Psychiatry at the University of Pittsburgh Medical Center. He is currently Editor-in-Chief of the journal Brain Sciences.

Event Committee

Dr. Kazuhito Toyooka

Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, USA

Dr. Toyooka is an assistant professor in the Department of Neurobiology & Anatomy at Drexel University College of Medicine. He did postdoctoral fellowships at the University of California San Diego and the University of California San Francisco. He also served on the faculty at Osaka City University School of Medicine in Japan. He was appointed to the faculty in the Department of Neurobiology & Anatomy at the College of Medicine in 2013.

Dr. Corrado Romano

Department of Biomedical Sciences and Biotechnologies (Biometec), The University of Catania, Catania, Italy,
Research Unit of Rare Diseases and Neurodevelopmental Disorders, The Oasi Research Institute-IRCCS, Troina, Italy

Prof. Corrado Romano is a graduate in Medicine and Surgery from the Catholic University of Sacred Heart School of Medicine and Surgery, Italy. His scientific background is also focused on pediatrics and Medical genetics. He has been working in the Oasi Research Institute-IRCCS at Troina for many years up to october 2021. In 2003, he became the Head of the Unit of Pediatrics and Medical Genetics, and in 2017, the Head of the Laboratory of Medical Genetics and of the Department of Laboratories at the same Institute. He was elected President of the local IRB for the term 2019–2022 on 22 July 2019. His scientific work is focused on Medical Genetics of Neurodevelopmental Disorders, contributing to the delineation of new genetic syndromes linked to neurodevelopmental disorders, such as 17q21.31 deletion, 15ql3.3 deletion, 1q21.1 deletion, 2q23.1 deletion, 16p12.1 deletion, 7ql1.23 duplication, and the Haploinsufficiency of ADNP, CHD8, DYRK1A, NAA15, DDX3X, ACTL6B, ADGRB3, FBX011, CSDE1, TANC2 and HnRNP genes. He has published more than 240 articles in international peer-reviewed scientific journals, with more than 9000 citations, as well as contributed as an Associate Editor for the Journals Frontiers in Pediatrics, Frontiers in Public Health, Frontiers In Genetics and Brain Sciences. He has also been invited as Chairman and Speaker in several national and international meetings. Since 2005, he has held, in Troina, with an International Scientific Committee, an International Meeting on the Genetics of Neurodevelopmental Disorders, which has reached its 15th Edition. Since november 2021, he has been appointed by the University of Catania as Associate Professor of Medical Genetics within the Section of Medical Biochemistry at the Department of Biomedical and Biotechnological Sciences. Under a shared platform of scientific collaboration he’s Head of the Research Unit of Rare Diseases and Neurodevelopmental Disorders at the Oasi Research Institute-IRCCS in Troina.

Dr. Robert E. Kelly

Department of Psychiatry, Weill Cornell Medicine, White Plains, USA

I am a psychiatrist on faculty at Weill Cornell Medicine and am the Psychiatric Diseases Section Editor for Brain Sciences. I see patients admitted to New York-Presbyterian Hospital, teach students (medical, psychiatry, geriatric psychiatry, psychology, nursing, and nurse practitioner), conduct research projects, and support other research activities as a journal reviewer and editor. My background: After graduating from Caltech with a degree in Engineering and Applied Science I worked for IBM developing computer graphics methods and leading a natural language project, before shifting to the study of the human body and mind (medical degree from Lund University). During my NIH-funded research fellowship in geriatric mood disorders and neuroimaging (mentor George Alexopoulos), I focused on research methodology. My most recent work aims to improve fMRI methods and the productivity of our scientific endeavors.

Prof. Dr. Hasan Ayaz

School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, USA

Hasan Ayaz, Ph.D. is Provost Solutions Fellow and Associate Professor at the School of Biomedical Engineering, Science and Health Systems with affiliations at the Department of Psychological and Brain Sciences, and Solutions Institute at Drexel University, Adjunct Professor at the University of Pennsylvania, and Associate Fellow at the Children's Hospital of Philadelphia; and a core member of the Cognitive Neuroengineering and Quantitative Experimental Research Collaborative. He directs the Drexel Neuroergonomics Research Core, focusing on understanding human brain functioning using mobile neuroimaging in realistic and real-world environments, across the lifespan and from healthy (typical to specialized groups) to diverse clinical conditions (mental health to neurological). His research aims to design, develop, and utilize (i.e., to measure->elucidate->enable) next generation brain imaging for neuroergonomic applications over a broad spectrum from aerospace to healthcare. He organized and chaired multiple international conferences on this as well as research topics dedicated to mobile neurotechnology and studying brain at work and everyday life.

Dr. Daman Kumari

Section on Gene Structure and Disease, Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, USA

Dr. Daman Kumari is a Staff Scientist in the Laboratory of Cell and Molecular Biology at the National Institutes of Health. She received her PhD in Life Sciences from the Jawaharlal Nehru University in New Delhi, India. Dr. Kumari studies the mechanism of repeat expansion mediated silencing of the FMR1 gene in fragile X syndrome. Dr. Kumari serves on the editorial board of Brain Sciences.

Dr. Caroline Schnakers

Research Institute, Casa Colina Hospital and Centers for Healthcare, Pomona, USA

I have been working as a clinical scientist in the neurorehabilitation field for the past 15 years. I focus my research on brain-injured patients with Disorders of Consciousness (DOC) and, more particularly, on the assessment of their brain activity and cognitive functions using behavioral, electrophysiological and neuroimaging techniques. I have published more than 100 articles (H-index: 53) in international peer reviewed journals such as Neurology, Annals of Neurology, Nature Reviews Neurology and Lancet. I serve as the chair of the Special Interest Group on DOC for the International Brain Injury Association and I am actively involved in the Curing Coma Campaign. I currently work as assistant director at the Research Institute of Casa Colina Hospital and Centers for Healthcare (Pomona, CA).

Dr. Marco Cavallo

Faculty of Psychology, eCampus University, Novedrate (Como), Italy

Associate Professor in Clinical Psychology (Clinical Neuropsychology) at the eCampus University of Novedrate (Como, Italy). Director of the Clinical Psychology Service, Saint George Foundation, Cavallermaggiore (Cuneo, Italy). Past: 2008-2012: Chair of the Forum of Young Researchers (FYRE) of the World Federation of Neurology - Research Group on Aphasia, Dementia and Cognitive Disorders (WFN-RGADCD). EDUCATION 2009-2012 Four-year certified clinical training in Psychotherapy (Turin, Italy). 2005-2008 Ph.D. in Cognitive Science – The University and the Polytechnic of Turin, Italy, with a Ph.D. dissertation about the cognitive assessment of patients affected by neuro- degenerative conditions. 2007-2008 M.Sc. in Human Cognitive Neuropsychology - The University of Edinburgh, Scotland (UK). 2003 Graduate in Psychology, The University of Turin. Graduated with honours. FIELD OF RESEARCH (KEYWORDS) Neuropsychology: Neuropsychological rehabilitation; cognitive functions; experimental and clinical studies of traumatic brain injuries and neurodegenerative diseases; neuropsychological assessment. Psychiatry and Clinical Psychology: Design and implementation of multi-centric clinical trials to investigate patients’ adherence to therapeutic interventions; evaluation of clinical interventions; Depression; CBT; EMDR. Foundations of cognitive sciences: Mind and brain correlations; theory of mind; mental states. I have authored more than 40 scientific publications on International peer-reviewed scientific journals (please see details here:

Dr. Tjeerd Olde Scheper

School of Engineering, Computing and Mathematics, Oxford Brookes University, Oxford, UK

Dr Tjeerd V. olde Scheper works in the School of Engineering, Computing, and Mathematics at Oxford Brookes University (UK). His research is in Dynamic Systems and Neurocomputation. He is particularly interested in the manner in which Biological Systems resolve problems in dynamics, and in mechanisms to apply those concepts to Engineering, Health, and Medical problems. He developed and patented a control method called Rate Control of Chaos, which limits the nonlinear dynamics of complex control problems into stable control domains with wide ranges of application in control of Wind turbines, Bioreactors and Engine control. He also created a method for nonlinear data representation Criticality Analysis that allows improved machine learning performance and the analysis of dynamic biological data. He also developed the concept of Dynamic Hebbian Learning that allows STDP to emerge from local dynamic interactions within a dendrite.

Dr. Min Zhou

Department of Neuroscience, Ohio State University Columbus, USA

Dr. Min Zhou is an Associate Professor of Neuroscience at the Ohio State University Wexner Medical Center. Dr. Zhou’s NIH-funded research focuses on the physiology and pathophysiology of astrocytes, a glial subtype that are linked through conduit proteins, gap junctions, into a syncytium. The syncytial coupling has been indicated in his recent study to confer an isopotentiality to astrocytes network, by which astrocytes operate as a functional system in brain homeostasis. In ongoing studies, he is investigating 1) the anatomical basis, gap junction, ion channel mechanisms and biophysical rationale underlying this newly appreciated glial mechanism; 2) how neuronal signaling regulates the functional states of astrocyte syncytium, and that in turn, subserves brain homeostasis and synaptic transmission; and 3) how disruption of an astrocyte syncytium, at both of the structural and functional levels, is etiologically associated with neurological disorders, such as stroke, epilepsy, and depression. Dr. Zhou is an Associate Editor of Frontiers in Physiology, serves for the editorial boards of Brain Sciences Neuroglia Section, Neural Regeneration Research and others.

Dr. Susana Pinto

Faculty of Medicine, University of Lisbon, Lisbon, Portugal,
Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal

Dr. Susana Pinto is a consultant in Physical Medicine and Rehabilitation in Akademiska sjukhuset, Uppsala, Sweden and a clinical researcher at Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal as well as an Invited Associate Professor at Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. Interested in neuro rehabilitation and respiratory rehabilitation, neurophysiology, phenotype-genotype, sensors, telemonitoring, new technologies.

Prof. Dr. Giuseppe Vallar

Department of Psychology, University of Milano-Bicocca, 20126 Milan, Italy

Giuseppe Vallar, MD, is Professor Emeritus of Psychobiology and Physiological Psychology in the Department of Psychology of the University of Milano-Bicocca, Milan, Italy. Neuropsychology, with studies investigating disorders of human cognition caused by brain damage, is the main research interest. Topics include disorders of spatial cognition (specifically, the syndrome of unilateral spatial neglect, in its clinical manifestations, neurofunctional architecture, modulation by sensory signals in the short-term and for long-term rehabilitation), the neurofunctional architecture of verbal short-term memory, the effects of electrical and magnetic stimulations on cognitive processes, apraxia, the methodological foundation and the history of neuropsychology. He is the author of over 250 publications and the co-editor of several books on spatial cognition, short-term memory, and, in 2018, of ”The parietal lobe”, a volume of the Handbook of Clinical Neurology series.

Session Chairs

Prof. Dr. Pierluigi Zoccolotti

Department of Psychology, Sapienza University of Rome, Rome, Italy

Session 4. Neuropsychology
Pierluigi Zoccolotti is currently full professor of General Psychology in the Department of Psychology of the Sapienza University of Rome. He teaches Psychology of Learning Disabilities in the “Cognitive Neurosciences and Psychological Rehabilitation” international graduate program, participates in the PhD program in “Behavioral Neurosciences” and in the post-graduate School of Specialization in “Neuropsychology” and coordinates the post-graduate master program in “Disturbances of learning and cognitive development”. Across the years, research interests spanned various areas of cognitive psychology and experimental and clinical neuropsychology, including studies on human lateralization, visuo-spatial neglect and attentional disturbances in patients with vascular etiology, traumatic brain lesions or Alzheimer disease. He also worked on the development of cognitive rehabilitation programs for spatial neglect and hemianopia. Since the late 90’s his research has focused on developmental reading and spelling deficits. This theme was examined in studies ranging from perception to eye movements and psycholinguistic analysis. As part of this interest, he also developed various test materials and rehabilitation trainings.

Prof. Dr. Konstantin V. Slavin

Department of Neurosurgery, University of Illinois at Chicago, Chicago, USA

Session 5. Systems Neuroscience
Konstantin Slavin, MD, FAANS is Professor, Chief of Section and Fellowship Director for Stereotactic and Functional Neurosurgery in the Department of Neurosurgery at the University of Illinois at Chicago (UIC). Dr. Slavin graduated from medical school in Baku, Azerbaijan in the Soviet Union and completed his neurosurgery residency in Moscow. He then completed his second neurosurgery residency at UIC and a fellowship in functional and stereotactic neurosurgery at Oregon Health Sciences University in Portland, OR. Dr. Slavin is the Past President of the American Society for Stereotactic and Functional Neurosurgery and current Vice-President of the World Society for Stereotactic and Functional Neurosurgery. He is also the President-Elect of the International Neuromodulation Society (INS) and past Secretary of the North American Neuromodulation Society (NANS). For many years, he was an Executive Committee member of the Joint Section on Pain of the American Association of Neurological Surgeons and Congress of Neurological Surgeons. Among many honors and awards he is particularly proud to be an Honorary Professor of the Burdenko Neurosurgical Institute in Moscow. Dr. Slavin is published in many books and peer-reviewed journals and is an associate editor or editorial board member for a number of publications, including Neuromodulation, Neurosurgery, Brain Sciences, Stereotactic and Functional Neurosurgery, Acta Neurochirurgica and others; he is the current editor-in-chief of Progress in Neurological Surgery. His first book on Peripheral Nerve Stimulation was published in 2011; another book, co-edited with Sam Eljamel on Neurostimulation: Practice and Principles, came out in 2013; the third one, Stimulation of Peripheral Nervous System: The Neuromodulation Frontier was released in 2015. The most recent book on Neuromodulation for Facial Pain came out in 2021.

Prof. Dr. Zubair Ahmed

Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK

Session 8. Neurorehabilitation
Zubair Ahmed completed a PhD in Plastic Surgery at University College London where he investigated a tissue engineering approach to repairing peripheral nerves using artificial biological matrices. He then moved to the Institute of Neurology in London to investigate the mechanisms of disease development in Multiple Sclerosis. He then to the University of Birmingham in 2002 where he investigated the mechanisms behind why central nervous system axons fail to regenerate and developed strategies to combat these complications. He was awarded an RCUK Academic Fellowship in NeuroRegeneration in 2007 to develop his own independently funded research programme on themes such as neuroprotection in the eye and neuro-restoration after spinal cord injury. In 2011 he was promoted to Lecturer, then to Senior Lecturer in 2013 and to Professor in Neuroscience in 2021. He continues to investigate the molecular mechanisms underpinning the failure of central nervous system neurons to regenerate after injury and disease. He currently leads the Neuroscience and Ophthalmology Section, a group of diverse clinicians and scientists interested in all aspects of trauma and disease affecting the eye, brain and spinal cord. He is and Editorial Board Member for Brain Sciences and Trauma Care (both from MDPI).

Dr. Evanthia Bernitsas

Multiple Sclerosis Center, Neurology Department, Wayne State University, Detroit, USA

Session 9. Neurotechnology and Neuroimaging
Dr. Bernitsas is a board-certified neurologist and a Multiple Sclerosis expert. After graduating from Aristotle Medical School, Thessaloniki, Greece, she completed a residency at the Case Western Reserve Medical School/University Hospitals in Cleveland and a Neuroimmunology Fellowship at Baylor College of Medicine and University of Michigan Medical Center. Currently, she is the Director of the Multiple Sclerosis/Neuroimmunology Center at Wayne State School of Medicine, Detroit and an Associate Professor of Neurology. Dr. Bernitsas has leaded a high number of clinical trials and investigator-initiated studies, published extensively, and participated in several advisory boards and steering committees.

Live Session Information

During the duration of the conference, a number of live online sessions will be programmed. The live streaming platform we are using is Zoom. During each session, the participants will have the possibility to ask questions during a Q&A session. Detailed information about the topics and dates will be shared soon.

The live sessions are free for authors. The authors who submit submissions to IECBS 2022 will have priority for the registration (with no extra cost) to the live online sessions with our invited speakers. If it is not completely full, the registration will be opened for unregistered participants. Registrations with academic institutional email addresses will be prioritized. The number of participants in the live session is limited but the recording will be made available on Sciforum shortly afterwards.

For our invited speakers, IECBS 2022 would like to grant an award for our best speaker presented in the live sessions of the conference. The winner will receive a certificate, 300 CHF and an opportunity to publish a paper in Brain Sciences with a voucher of 1000 CHF before 1 June 2023.

Instructions for Authors

Generic information

The registration for this conference is FREE and the works selected for their presentation on the conference will be published as conference proceedings with no cost.

Submissions should be done by the authors online by registering with, and using the "Start New Submission" function once logged into system. There is no limit of abstracts presented by one author.

  1. Scholars interested in participating within the conference can submit their abstract online on this website until 25 July 2022. The abstract submitted should be about 200-word in English - the word limits are minimum 150 words and maximum 250 words.
  1. The Conference Committee will evaluate the abstracts received and decide whether the contribution from the authors of the abstract will be welcome for conference. All the authors will be notified about the acceptance of their works by 5 August 2022.
  1. If the abstract is accepted for this conference, the authors will be asked to submit an extended manuscript (download the word template here and latex template here) optionally along with a poster and/or PowerPoint presentation of his/her paper (only PDF), up to the full manuscript submission deadline of 5 September 2022.
  1. The conference proceedings papers and presentations will be available at for discussion during the time of the conference, 01–15 October 2022, and will be published in Journal Biology and Life Sciences Forum.
After the conference, the Conference Committee will select manuscripts that may be included for publication in a Special Issue of the journal Brain Sciences. Those papers will be offered a 20% discount over the normal APC of the journal.
Note that the submission to the journal is independent of the conference proceedings and will follow the usual process of the journal, including peer-review, etc.
Conference Paper

Manuscripts for the proceedings issue must have the following organization:

First page:

  • Title
  • Full author names
  • Affiliations (including full postal address) and authors' e-mail addresses (institutional addresses preferred)
  • Abstract (200–250 words)
  • Keywords


  • Introduction
  • Methods
  • Results and Discussion
  • Conclusions
  • (Acknowledgements)
  • References
Manuscripts should be prepared in MS Word or any other word processor and should be converted to PDF format before submission. The publication format will be PDF. The manuscript should be at least 3 pages (incl. figures, tables and references) and should not exceed 6 pages.
Please carefully read the rules outlined in the 'Instructions for Authors' on the journal website and ensure that your manuscript submission adheres to these guidelines.

Manuscript Preparation

  • Paper Format: A4 paper format, the printing area is 17.5 cm × 26.2 cm. The margins should be 1.75 cm on each side of the paper (top, bottom, left, and right sides).
  • Paper Length: The conference proceedings paper should not be longer than 6 pages. The conference manuscript should be as concise as possible.
  • Formatting/Style: The paper style of the journal Proceedings should be followed. You may download the template file to prepare your paper (see above). The full titles of the cited papers must be given. Reference numbers should be placed in square brackets [ ], and placed before punctuation; for example [4] or [1–3], and all the references should be listed separately and as the last section at the end of the manuscript.
  • Authors List and Affiliation Format: Authors’ full first and last names must be given. Abbreviated middle name(s) can be added. For papers written by various contributors, a corresponding author must be designated. The PubMed/MEDLINE format is used for affiliations: complete street address information including city, zip code, state/province, country, and email address should be added. All authors who contributed significantly to the manuscript (including writing a section) should be listed on the first page of the manuscript, below the title of the article. Other parties who provided only minor contributions should only be listed under Acknowledgments. A minor contribution might be a discussion with the author, reading through the draft of the manuscript, or performing English corrections.
  • Figures, Schemes, and Tables: Authors are encouraged to prepare figures and schemes in color. Full color graphics will be published free of charge. Figure and schemes must be numbered (Figure 1, Scheme I, Figure 2, Scheme II, etc.) and an explanatory title must be added. Tables should be inserted into the main text, and numbers and titles for all tables supplied. All table columns should have an explanatory heading. Please supply legends for all figures, schemes, and tables. The legends should be prepared as a separate paragraph of the main text and placed in the main text before a table, figure, or scheme.

Presentation Poster or Slides

Authors are encouraged to prepare a poster or a collection of slides in PowerPoint or similar software, to be displayed online along with the manuscript. Authors that wish to present only a poster, i.e., without a proceedings paper, can do it too.
Slides, if available, will be displayed directly in the website using the proprietary slides viewer at Slides can be prepared in the same way as for any traditional conference where research results are presented. Both posters and slides should be converted to PDF format before submission so that our process can easily and automatically convert them for online display.

Posters should have the following information.

  • Title (with authors and affiliations)
  • Introduction / Objectives / Aims
  • Methods
  • Results
  • Conclusions
  • References
  • Acknowledgements
  • Contact information

Potential Conflicts of Interest

It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state here "The authors declare no conflict of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Financial support for the study must be fully disclosed under "Acknowledgments" section.


MDPI, the publisher of the platform, is an open access publisher. We believe that authors should retain the copyright to their scholarly works. Hence, by submitting a Conference paper to this conference, you retain the copyright of your paper, but you grant MDPI the non-exclusive right to publish this paper online on the platform. This means you can easily submit your paper to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).

Event Awards

To acknowledge the support of the conference esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to launch the following awards:

The Awards
Best Paper Award
The Best Paper Award is given to the paper judged to make the most significant contribution to the conference. There will be one winner selected for this award. The winner will receive a certificate, 300 CHF and an opportunity to publish a paper in Brain Sciences with a voucher of 1000 CHF before 1 June 2023.
Best Poster Award
The Best Poster Award is given to the submission judged to make the most significant and interesting poster for the conference. There will be one winner selected for this award. The winner will receive a certificate, 300CHF and an opportunity to publish a paper in Brain Sciences with a voucher of 1000 CHF before 1 June 2023.
Terms and Conditions:

1. Full paper/poster must be submitted to IECBS 2022.
2. The quality of the paper/poster.
3. The scientific content of the paper/poster.


1. Each Evaluation Committee member will give an assessment for each paper/poster in terms of the criteria outlined above.
2. The score for each paper/poster will be ranked, from highest to lowest.
3. If two or more papers/posters get the same score, further evaluation will be carried out.
4. All decisions made by the Evaluation Committee are final.

Conference Secretariat

Ms. Bonnie Wu

Ms. Gem Yao

MDPI Branch Office, Beijing

Email: [email protected]

For information regarding submission inquiry and sponsoring opportunities, please feel free to contact us.

Sponsors and Partners


Media Partners